{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:32:11Z","timestamp":1787005931161,"version":"build-2736575974"},"reference-count":59,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T00:00:00Z","timestamp":1293753600000},"content-version":"vor","delay-in-days":1126,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2007,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary fallopian tube carcinoma (PFTC) is rare, constituting about 1% of female genital tract malignancies, and little is known about its etiological, protective, risk or prognostic factors. Earlier, such factors were thought to be similar to those seen in ovarian cancer. The incidence of PFTC has been rising during the last decades, especially in higher social classes and among women in certain occupations. Parity is a strong protective factor for PFTC, with a lower incidence associated with an increasing number of deliveries. Previous sterilisation seems to offer some protection. Earlier suggestions of previous genital infections as risk factors appear not to hold. Previous cancers are frequent among PFTC patients, especially breast cancer. Second primary cancers after PFTC are also frequent, especially non\u2010lymphoid leukemia, colorectal, breast, bladder and lung cancer. Only 4% of primary fallopian carcinomas are correctly diagnosed before operation. Treatment consists of aggressive cytoreductive surgery and adjuvant chemotherapy with a platinum\u2010taxane combination. A high preoperative serum hCG\u00df is a strong prognostic factor for worse prognosis. The 5\u2010year survival rates vary between 22 and 57%.<\/jats:p>","DOI":"10.1080\/00016340701771034","type":"journal-article","created":{"date-parts":[[2007,11,17]],"date-time":"2007-11-17T07:28:55Z","timestamp":1195284535000},"page":"1419-1426","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Updating on primary fallopian tube carcinoma"],"prefix":"10.1111","volume":"86","author":[{"given":"ANNIKA","family":"RISKA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ARTO","family":"LEMINEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,31]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001115)89:10<2076::AID-CNCR7>3.0.CO;2-V"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-199102000-00013"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349209009923"},{"key":"e_1_2_4_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5267"},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000090155"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(89)90051-6"},{"key":"e_1_2_4_8_2","volume-title":"SEER program. 12 geographic areas for 1995\u20131999","author":"National Cancer Institute","year":"2001"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443610500292395"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841868909111173"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1994.04060395.x"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10970"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0274(199907)36:1<83::AID-AJIM12>3.0.CO;2-Q"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-200104000-00003"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1080\/0144361031000074808"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.11.041"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2006.01256.x"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-199807000-00009"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22491"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.02.025"},{"key":"e_1_2_4_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10267"},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011253527605"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008860615584"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6095"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.pgp.0000101082.35393.84"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000187892.78392.3f"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3835(00)00335-9"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2147"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.4519"},{"key":"e_1_2_4_30_2","doi-asserted-by":"publisher","DOI":"10.1159\/000010212"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ogx.0000158506.23663.79"},{"key":"e_1_2_4_32_2","volume-title":"Pathology and genetics of tumors of the breast and female genital organs","author":"Tavassoli FA","year":"2003"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(90)90321-B"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.05.0491"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(84)90444-7"},{"key":"e_1_2_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(87)90022-0"},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02391799"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001001)89:7<1555::AID-CNCR20>3.0.CO;2-J"},{"key":"e_1_2_4_39_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-91-4-1030"},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0215(20010920)95:5<313::AID-IJC1054>3.0.CO;2-Q"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.1993.03020065.x"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006254-199405000-00026"},{"key":"e_1_2_4_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2001.011001069.x"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00292.x"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.11-8-902"},{"key":"e_1_2_4_46_2","first-page":"153","volume-title":"Lymphatic system of the female genitalia","author":"Plentl A","year":"1971"},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)32579-0"},{"key":"e_1_2_4_48_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1996.0215"},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(16)41439-8"},{"key":"e_1_2_4_50_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200202000-00005"},{"key":"e_1_2_4_51_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.1222"},{"key":"e_1_2_4_52_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.6012"},{"key":"e_1_2_4_53_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2002.6743"},{"key":"e_1_2_4_54_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.14.2733"},{"key":"e_1_2_4_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22562"},{"key":"e_1_2_4_56_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.1996.82910.x"},{"key":"e_1_2_4_57_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.50.070181.002341"},{"key":"e_1_2_4_58_2","first-page":"1553","article-title":"The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti\u2010apoptosis effect and not cell proliferation","volume":"82","author":"Butler SA","year":"2000","journal-title":"Br J Cancer"},{"key":"e_1_2_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2006.02.019"},{"key":"e_1_2_4_60_2","first-page":"276","article-title":"Designing a new generation of anti\u2010hCG vaccines for cancer therapy","volume":"260","author":"Delves PJ","year":"2006","journal-title":"Mol Cell Endocrinol"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F00016340701771034","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1080\/00016340701771034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T03:15:08Z","timestamp":1695784508000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1080\/00016340701771034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":59,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["10.1080\/00016340701771034"],"URL":"https:\/\/doi.org\/10.1080\/00016340701771034","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"2010-12-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}